Erratum: Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients (Journal of Clinical Pharmacology (2010) 50: 4 (450-458) DOI: 10.1177/0091270009359182)

Scopus Publication Detail

The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.

S. Borges; Z. Desta; Y. Jin; A. Faouzi; J.D. Robarge; S. Philip; A. Nguyen; V. Stearns; D. Hayes; J.M. Rae; et al. (Profiled Authors: Lang Li; Zeruesenay Desta; David A. Flockhart; Todd C. Skaar)

Journal of Clinical Pharmacology. 2010;50(6):725.

Scopus

Full text |

Abstract

Due to policies set forth between SciVerse Scopus and this publisher, the abstract cannot be displayed here.

Scientific Context

This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.

Medicine & Life Sciences

Related Publications

1.
2011

William J. Irvin Jr.; Christine M. Walko; Karen E. Weck; Joseph G. Ibrahim; Wing K. Chiu; E. Claire Dees; Susan G. Moore; Oludamilola A. Olajide; Mark L. Graham; Sean T. Canale; et al.

Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: A multicenter study
Journal of Clinical Oncology. 2011;29(24):3232-3239.
2.
2011

Matthew P. Goetz; Daniel J. Schaid; D. Lawrence Wickerham; Stephanie Safgren; Taisei Mushiroda; Michiaki Kubo; Anthony Batzler; Joseph P. Costantino; Victor G. Vogel; Soonmyung Paik; et al.

Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: Results from the NSABP P1 and P2 clinical trials
Clinical Cancer Research. 2011;17(21):6944-6951.
3.
2010

Silvana Borges; Zeruesenay Desta; Yan Jin; Azzouz Faouzi; Jason D Robarge; Sanosh Philips; Anne Nguyen; Vered Stearns; Daniel Hayes; James M Rae; et al.

Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients.
Journal of clinical pharmacology. 2010;50(4):450-458.